Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
about
Chloride intracellular channel 1 regulates the antineoplastic effects of metformin in gallbladder cancer cells.Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism.Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models.p53 and metabolism: from mechanism to therapeutics.Hsa-miRNA-143-3p Reverses Multidrug Resistance of Triple-Negative Breast Cancer by Inhibiting the Expression of Its Target Protein Cytokine-Induced Apoptosis Inhibitor 1Effect of metformin on the survival of patients with ALL who express high levels of the ABCB1 drug resistance gene
P2860
Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting P-glycoprotein funct ...... CF-7/Dox cells to doxorubicin.
@en
Targeting P-glycoprotein funct ...... CF-7/Dox cells to doxorubicin.
@nl
type
label
Targeting P-glycoprotein funct ...... CF-7/Dox cells to doxorubicin.
@en
Targeting P-glycoprotein funct ...... CF-7/Dox cells to doxorubicin.
@nl
prefLabel
Targeting P-glycoprotein funct ...... CF-7/Dox cells to doxorubicin.
@en
Targeting P-glycoprotein funct ...... CF-7/Dox cells to doxorubicin.
@nl
P2093
P2860
P356
P1433
P1476
Targeting P-glycoprotein funct ...... CF-7/Dox cells to doxorubicin.
@en
P2093
Changyuan Wang
Chaojun Xue
Huijun Sun
Jinyong Peng
Pengyuan Sun
Qiang Meng
Xiaochi Ma
Xiaodong Ma
Yaoting Sun
P2860
P304
P356
10.18632/ONCOTARGET.14373
P407
P50
P577
2016-12-30T00:00:00Z